Brief Research Report
Accepted on 29 Sep 2025
Low-dose emapalumab treatment in refractory macrophage activation syndrome secondary to adult onset still’s disease/systemic lupus erythematosus: insights from nine cases
in Inflammation
Brief Research Report
Accepted on 29 Sep 2025
in Inflammation
Original Research
Accepted on 29 Sep 2025
in Inflammation
Review
Accepted on 29 Sep 2025
in Inflammation
Original Research
Accepted on 29 Sep 2025
in Soft Robotics
Original Research
Accepted on 29 Sep 2025
in Human-Robot Interaction
Review
Accepted on 29 Sep 2025
in Neuropsychology
Opinion
Accepted on 29 Sep 2025
in Mindfulness
Original Research
Accepted on 29 Sep 2025
in Bilingualism
Review
Accepted on 29 Sep 2025
in Food Biotechnology
Perspective
Accepted on 29 Sep 2025
in Technical Advances in Plant Science
Review
Accepted on 29 Sep 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 29 Sep 2025
in Neurological Biomarkers
Original Research
Accepted on 29 Sep 2025
in Plant Physiology
Original Research
Accepted on 29 Sep 2025
in Headache and Neurogenic Pain
Review
Accepted on 29 Sep 2025
in Stroke
Original Research
Accepted on 29 Sep 2025
in Plant Biophysics and Modeling